Patients Receiving Induction With Liposomal Daunorubicin and Cytarabine (CPX-351) for Acute Myeloid Leukemia
NCT03988205
·
clinicaltrials.gov ↗
PHASE4
Phase
TERMINATED
Status
3
Enrollment
OTHER
Sponsor class
Stopped
Low accrual
Conditions
Leukemia, Myeloid, Acute
Interventions
BEHAVIORAL:
Outpatient Care Model
DRUG:
CPX-351
Sponsor
Medical College of Wisconsin